HALEON US HOLDINGS LLC for HALEON US HOLDINGS LLC
What was lobbied
20 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General monitoring of legislative and administrative action related to Medicare and Medicaid policy, including changes in coverage/eligibility. General monitoring of Medicare coverage of dental services; General review of legislation, rulemaking impacting dual eligible enrollees
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Agriculture AGR
General review and monitoring of farm bill legislation, particularly provisions related to nutrition. Monitor on legislative and administrative action related to White House Conference on Hunger; H.R.3087 - Training and Nutrition Stability; S.2131 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Family issues/Abortion/Adoption FAM
General review of federal policies applying towards paid family and medical leave. General review of legislative and administration action related to pediatric over-the-counter concerns.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Pharmacy PHA
General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process; and Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Consumer Issues/Safety/Products CSP
General review and monitoring of legislative and administrative actions on banning noncompete clauses; Modernization of Cosmetics Regulation Act of 2022 (MoCRA) implementation; and General review and monitoring of legislative and administrative actions related to the design, development, and deployment of artificial intelligence platforms, especially as related to healthcare and protection of personally identifiable information.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Copyright/Patent/Trademark CPT
General monitoring of legislative and administrative action related to intellectual property protection.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Tobacco TOB
Preventing youth consumption of tobacco products; Smoking cessation and over-the-counter alternatives for adult consumers; and General review of legislation and administrative action allowing for original Medicare and Part D coverage of over-the-counter smoking cessation products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Manufacturing MAN
General issues related to the manufacturing and supply chain resiliency of over-the-counter medications; and H.R. 3622 Cosmetic Supply Chain Transparency Act. General review and monitoring of Modernization of Cosmetics Regulation Act of 2022 implementation. Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Health Issues HCR
General monitoring of legislative and administrative action related to health care policy; General monitoring of legislative and administrative action related to womens health issues; General monitoring of legislative and administrative action related to over-the-counter consumer healthcare products; General monitoring of legislative and administrative action related to dietary supplements, multivitamin, and hunger issues; General monitoring of legislative and administrative action related to servicing of medical device equipment; General monitoring of legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP); General monitoring of legislative and administrative action related to FDA monograph reform and user fees; General monitoring of legislative and administrative action related to the switch of prescription medications to over-the-counter medications; Review of issues related to Prescription Drug User Fee Act Reauthorization (PDUFA); Review of coverage for medically necessary services in Medicare and Medicare Advantage, including dental coverage, to address underlying conditions in advance of major surgery; General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation. General monitoring of issues related to the reauthorization of "Pandemic and All-Hazards Preparedness Act" PAHPA Defense Production Act (DPA) issues, specifically on manufacturing impacts on over-the-counter medications. S. 818 Maximizing Opioid Recovery Emergency Savings Act, in particular, provisions related to drugs and biologicals; Review of legislation impacting the Dietary Supplement Health and Education Act of 1994, in particular, provisions related to Mandatory Product Listing (MPL); and S. 923, Better Mental Health Care for Americans Act, specifically provisions related to substance use disorders. H.R. 831 Medicare Medically Necessary Dental Care Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Labor Issues/Antitrust/Workplace LBR
General review of federal policies applying towards paid family and medical leave.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Budget/Appropriations BUD
Implementation of H.R. 5376, Inflation Reduction Act of 2022; FY 2024 Appropriations for NIH, NCI, CDC, FDA, and related preventive healthcare accounts; FY2024 Labor, Health and Human Services, Education and Related Agencies (LHHS-ED) Appropriations; H.R.4394 - Energy and Water Development and Related Agencies Appropriations Act, 2024; H.R.4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; and H.R. 4365 Department of Defense Appropriations Act, 2024 S.2131 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 S.2624 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 S.2443 - Energy and Water Development and Related Agencies Appropriations Act, 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Civil Rights/Civil Liberties CIV
General review and monitoring of legislative and administrative actions related to societal issues or justice; and General health inclusivity issues;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Defense DEF
H.R. 2670 National Defense Authorization Act for Fiscal Year 2024 S.2587 - Department of Defense Appropriations Act, 2024 H.R.4365 - Department of Defense Appropriations Act, 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Taxation/Internal Revenue Code TAX
Implementation of H.R. 3684, Infrastructure Investment and Jobs Act; General monitoring of Issues related to federal tax amortization of research and development expenses; General review and monitoring of legislation that includes over-the-counter dietary supplement products, specifically multivitamins, as qualified medical expenses; General review and monitoring of legislation and administrative action related to oral healthcare products, including specialty toothpastes and rinses, as qualified medical expenses under HSA/FSA
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Trade (domestic/foreign) TRD
General international trade policy related to tariffs, import, export concerns. General monitoring of legislative and administrative action related to foreign regulation of chemicals, ingredients, and health care products. General monitoring of legislative and administrative action related to implementation of the United States-Mexico-Canada Agreement (USMCA) WTO Covid TRIPS waiver proposal General review and monitoring of supply chain concerns, including impact of Russian invasion of Ukraine.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Food Industry (safety, labeling, etc.) FOO
Multivitamin and nutrition issues. Review of legislative or administrative action related to melatonin, specifically gummy products on products labeled for adult use; and S Res 35 Resolution designating October 22 through October 28, 2023, as "Natural Product Industry Week"
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Environment/Superfund ENV
General monitoring of legislative and administrative action related to climate change; and General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings; and H.R. 2964/S.1350 Wastewater Infrastructure Pollution Prevention and Environmental Safety Act/WIPPES Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Government Issues GOV
General review of FDA rulemaking and processes on cannabis, specifically CBD, and associated proposed safety standards for CBD to be lawfully marketed as a dietary supplement or food additive. Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Energy/Nuclear ENG
General review and monitoring of renewable energy legislation and regulations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Foreign Relations FOR
General review and monitoring of U.S. diplomatic relations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| JONATHAN MARTINEZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.